144 related articles for article (PubMed ID: 9707372)
1. Combined effects of interferon-alpha and acyclovir on herpes simplex virus type 1 DNA polymerase and alkaline DNase.
Taylor JL; Tom P; O'Brien WJ
Antiviral Res; 1998 May; 38(2):95-106. PubMed ID: 9707372
[TBL] [Abstract][Full Text] [Related]
2. The effects of interferon-alpha and acyclovir on herpes simplex virus type-1 ribonucleotide reductase.
O'Brien WJ; Narasimhan J; Guy J; Tom P; Taylor JL
Antiviral Res; 1998 May; 38(2):107-16. PubMed ID: 9707373
[TBL] [Abstract][Full Text] [Related]
3. Combined anti-herpes virus activity of nucleoside analogs and interferon.
Taylor JL; Punda-Polic V; O'Brien WJ
Curr Eye Res; 1991; 10 Suppl():205-11. PubMed ID: 1650669
[TBL] [Abstract][Full Text] [Related]
4. Regulation of herpes simplex virus thymidine kinase in cells treated with a synergistic antiviral combination of alpha interferon and acyclovir.
Taylor JL; Tom P; Guy J; Selvarajan RM; O'Brien WJ
Antimicrob Agents Chemother; 1994 Apr; 38(4):853-6. PubMed ID: 8031058
[TBL] [Abstract][Full Text] [Related]
5. 2',5'-oligoadenylate synthetase in interferon-alpha- and acyclovir-treated herpes simplex virus-infected cells.
Taylor JL; Witt PL; Irizarry A; Tom P; O'Brien WJ
J Interferon Cytokine Res; 1995 Jan; 15(1):27-30. PubMed ID: 7648430
[TBL] [Abstract][Full Text] [Related]
6. Synergistic anti-varicella-zoster virus activity of interferon-alpha 2a and acyclovir in corneal cells.
Punda-Polić V; O'Brien WJ; Taylor JL
Zentralbl Bakteriol; 1999 Apr; 289(2):203-10. PubMed ID: 10360320
[TBL] [Abstract][Full Text] [Related]
7. [Research of suppression of the herpes simplex virus reproduction with drug resistance by combination phosphite of acycloguanosine with some antiherpetic drugs].
Andronova VL; Jasko MV; Kukhanova MK; Skoblov YS; Deryabin PG; Galegov GA
Vopr Virusol; 2014; 59(6):32-5. PubMed ID: 25929034
[TBL] [Abstract][Full Text] [Related]
8. Beta interferon plus gamma interferon efficiently reduces acyclovir-resistant herpes simplex virus infection in mice in a T-cell-independent manner.
Huang WY; Su YH; Yao HW; Ling P; Tung YY; Chen SH; Wang X; Chen SH
J Gen Virol; 2010 Mar; 91(Pt 3):591-8. PubMed ID: 19906941
[TBL] [Abstract][Full Text] [Related]
9. Synergistic effects of acyclovir and 3, 19-isopropylideneandrographolide on herpes simplex virus wild types and drug-resistant strains.
Priengprom T; Ekalaksananan T; Kongyingyoes B; Suebsasana S; Aromdee C; Pientong C
BMC Complement Altern Med; 2015 Mar; 15():56. PubMed ID: 25879785
[TBL] [Abstract][Full Text] [Related]
10. The synergistic effects of betulin with acyclovir against herpes simplex viruses.
Gong Y; Raj KM; Luscombe CA; Gadawski I; Tam T; Chu J; Gibson D; Carlson R; Sacks SL
Antiviral Res; 2004 Nov; 64(2):127-30. PubMed ID: 15498608
[TBL] [Abstract][Full Text] [Related]
11. Synergistic inhibition of herpesvirus replication by docosanol and antiviral nucleoside analogs.
Marcelletti JF
Antiviral Res; 2002 Nov; 56(2):153-66. PubMed ID: 12367721
[TBL] [Abstract][Full Text] [Related]
12. Bone marrow transplantation in a child with Wiskott-Aldrich syndrome latently infected with acyclovir-resistant (ACV(r)) herpes simplex virus type 1: emergence of foscarnet-resistant virus originating from the ACV(r) virus.
Saijo M; Yasuda Y; Yabe H; Kato S; Suzutani T; De Clercq E; Niikura M; Maeda A; Kurane I; Morikawa S
J Med Virol; 2002 Sep; 68(1):99-104. PubMed ID: 12210436
[TBL] [Abstract][Full Text] [Related]
13. The antiviral activity of the ribonucleotide reductase inhibitor BILD 1351 SE in combination with acyclovir against HSV type-1 in cell culture.
Lawetz C; Liuzzi M
Antiviral Res; 1998 Jul; 39(1):35-46. PubMed ID: 9754948
[TBL] [Abstract][Full Text] [Related]
14. Synergistic antiherpes virus activity of acyclovir and interferon in human corneal stromal cells.
Taylor JL; Casey MS; O'Brien WJ
Invest Ophthalmol Vis Sci; 1989 Mar; 30(3):365-70. PubMed ID: 2466806
[TBL] [Abstract][Full Text] [Related]
15. Expression of herpes simplex virus type 1 recombinant thymidine kinase and its application to a rapid antiviral sensitivity assay.
Shiota T; Lixin W; Takayama-Ito M; Iizuka I; Ogata M; Tsuji M; Nishimura H; Taniguchi S; Morikawa S; Kurane I; Mizuguchi M; Saijo M
Antiviral Res; 2011 Aug; 91(2):142-9. PubMed ID: 21669227
[TBL] [Abstract][Full Text] [Related]
16. Profile of anti-herpetic action of ASP2151 (amenamevir) as a helicase-primase inhibitor.
Yajima M; Yamada H; Takemoto M; Daikoku T; Yoshida Y; Long T; Okuda T; Shiraki K
Antiviral Res; 2017 Mar; 139():95-101. PubMed ID: 28027917
[TBL] [Abstract][Full Text] [Related]
17. Lactoferrin and lactoferricin inhibit Herpes simplex 1 and 2 infection and exhibit synergy when combined with acyclovir.
Andersen JH; Jenssen H; Gutteberg TJ
Antiviral Res; 2003 May; 58(3):209-15. PubMed ID: 12767468
[TBL] [Abstract][Full Text] [Related]
18. Identification and characterization of acyclovir-resistant clinical HSV-1 isolates from children.
Wang Y; Wang Q; Zhu Q; Zhou R; Liu J; Peng T
J Clin Virol; 2011 Oct; 52(2):107-12. PubMed ID: 21778105
[TBL] [Abstract][Full Text] [Related]
19. Antiviral activities of methylated nordihydroguaiaretic acids. 2. Targeting herpes simplex virus replication by the mutation insensitive transcription inhibitor tetra-O-methyl-NDGA.
Chen H; Teng L; Li JN; Park R; Mold DE; Gnabre J; Hwu JR; Tseng WN; Huang RC
J Med Chem; 1998 Jul; 41(16):3001-7. PubMed ID: 9685239
[TBL] [Abstract][Full Text] [Related]
20. Effect of interferon-alpha on the steady-state levels of thymine, thymidine, guanine, and guanosine metabolites in herpes simplex virus-type 1-infected cells.
O'Brien WJ; Piotrowski K; Taylor JL
Intervirology; 1995; 38(5):249-55. PubMed ID: 8724854
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]